These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29610042)

  • 21. Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review.
    Oliver SP; Murinda SE; Jayarao BM
    Foodborne Pathog Dis; 2011 Mar; 8(3):337-55. PubMed ID: 21133795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strengthening Health Products Regulatory Systems to Enhance Access to Quality Health Products in the Asia-Pacific.
    Lim JCW
    Ther Innov Regul Sci; 2018 Nov; 52(6):751-754. PubMed ID: 29714589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens.
    Helmy YA; Taha-Abdelaziz K; Hawwas HAE; Ghosh S; AlKafaas SS; Moawad MMM; Saied EM; Kassem II; Mawad AMM
    Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potency testing of veterinary vaccines: the way from in vivo to in vitro.
    Romberg J; Lang S; Balks E; Kamphuis E; Duchow K; Loos D; Rau H; Motitschke A; Jungbäck C
    Biologicals; 2012 Jan; 40(1):100-6. PubMed ID: 22075457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modern science for better quality control of medicinal products "Towards global harmonization of 3Rs in biologicals": The report of an EPAA workshop.
    Schutte K; Szczepanska A; Halder M; Cussler K; Sauer UG; Stirling C; Uhlrich S; Wilk-Zasadna I; John D; Bopst M; Garbe J; Glansbeek HL; Levis R; Serreyn PJ; Smith D; Stickings P
    Biologicals; 2017 Jul; 48():55-65. PubMed ID: 28596049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights in the Development and Uses of Alternatives to Antibiotic Growth Promoters in Poultry and Swine Production.
    Rahman MRT; Fliss I; Biron E
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Traditional herbal medicines worldwide, from reappraisal to assessment in Europe.
    van Galen E
    J Ethnopharmacol; 2014 Dec; 158 Pt B():498-502. PubMed ID: 25043781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing innovation into a registered product: From concept to regulatory approval.
    Rhodes L
    Theriogenology; 2018 May; 112():75-81. PubMed ID: 28716338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and regulation of biosimilars: current status and future challenges.
    Tsiftsoglou AS; Ruiz S; Schneider CK
    BioDrugs; 2013 Jun; 27(3):203-11. PubMed ID: 23553340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European regulation of herbal medicinal products on the border area to the food sector.
    Quintus C; Schweim HG
    Phytomedicine; 2012 Feb; 19(3-4):378-81. PubMed ID: 22070985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Brazilian market of herbal medicinal products and the impacts of the new legislation on traditional medicines.
    Carvalho ACB; Lana TN; Perfeito JPS; Silveira D
    J Ethnopharmacol; 2018 Feb; 212():29-35. PubMed ID: 28987598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The regulatory framework for complementary and alternative medicines in Europe].
    Knöss W; Stolte F; Reh K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment, promotion, commotion: antibiotic alternatives in food-producing animals.
    Allen HK; Levine UY; Looft T; Bandrick M; Casey TA
    Trends Microbiol; 2013 Mar; 21(3):114-9. PubMed ID: 23473629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
    Vlietinck A; Pieters L; Apers S
    Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A global regulatory science agenda for vaccines.
    Elmgren L; Li X; Wilson C; Ball R; Wang J; Cichutek K; Pfleiderer M; Kato A; Cavaleri M; Southern J; Jivapaisarnpong T; Minor P; Griffiths E; Sohn Y; Wood D
    Vaccine; 2013 Apr; 31 Suppl 2():B163-75. PubMed ID: 23598478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of genotoxicity of herbal medicinal products: a co-ordinated approach.
    Kelber O; Steinhoff B; Kraft K;
    Phytomedicine; 2012 Mar; 19(5):472-6. PubMed ID: 22301069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory structures for gene therapy medicinal products in the European Union.
    Klug B; Celis P; Carr M; Reinhardt J
    Methods Enzymol; 2012; 507():337-54. PubMed ID: 22365782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.